Skip to main content

Odonate Therapeutics, Inc.

ODTDelisted Jan 25, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001717452

Odonate Therapeutics, Inc. was delisted on Jan 25, 2022; its insiders filed their last Form 4 on Dec 10, 2021; 50 institutions reported holding it in 13F filings for Q4 2021, worth $32.7M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Odonate Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of ODT: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders8369−14
Shares32.6M32.9M+323.3K (+1.0%)
Value$111.6M$115.0M+$3.43M (+3.1%)

New holders (12)

Institutions that held Odonate Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ODT in Q2 2021
InstitutionSharesValue% of portfolio
EcoR1 Capital, LLC831,200$2.90M0.11%
Norges Bank340,600$1.19M0.00%
Healthcare of Ontario Pension Plan Trust Fund325,600$1.14M0.00%
Millennium Management LLC191,954$670.0K0.00%
Ergoteles LLC71,800$251.0K0.01%
HRT Financial LP42,718$149.0K0.00%
Marshall Wace North America L.P.39,890$139.0K0.00%
Parametric Portfolio Associates LLC19,259$67.0K0.00%
Susquehanna Fundamental Investments, LLC18,280$64.0K0.00%
Dynamic Technology Lab Private Ltd11,106$39.0K0.00%
Federated Hermes, Inc.187$1.00K0.00%
Lake Point Wealth Management200$1.00K0.00%

Sold out (26)

Institutions that held Odonate Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.